Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGHAM:M12 +4.25%88 EV-to-OCF is 9.52 as of Sep. 05, 2026, which is 41% below its 10-year median of 16.26. GuruFocus rates HAM:M12 with a GF Score™ of 88/100 and a GF Value™ of €15.79 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, M1 Kliniken AG ranks worse than 52.54% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, M1 Kliniken AG's Enterprise Value is €361.4 Mil.
M1 Kliniken AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €37.9 Mil. Therefore, M1 Kliniken AG's EV-to-OCF for today is 9.52.
The historical rank and industry rank for M1 Kliniken AG's EV-to-OCF or its related term are showing as below:
HAM:M12'
s EV-to-OCF Range Over the Past 10 Years
Min: -53.2 Med: 16.26 Max: 2345.85
Current: 9.17
During the past 12 years, the highest EV-to-OCF of M1 Kliniken AG was 2345.85. The lowest was -53.20. And the median was 16.26.
HAM:M12's EV-to-OCF is ranked worse than 52.54% of 118
companies
in the Medical Distribution industry
Industry Median: 7.96
vs HAM:M12: 9.17
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
M1 Kliniken AG's PE Ratio (TTM) for today is calculated as:
M1 Kliniken AG's share price for today is €19.62.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €1.190.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
M1 Kliniken AG EV-to-OCF Related Terms
M1 Kliniken AG EV-to-OCF Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG EV-to-OCF vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's EV-to-OCF falls into.
M1 Kliniken AG's current Enterprise Value is €361.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2025 was €37.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (HAM:M12) has a EV-to-OCF of 9.52 as of Sep. 05, 2026. This is 41% below median its historical median of 16.26. According to the industry distribution chart, M1 Kliniken AG ranks #62 out of 118 companies in the Medical Distribution industry, placing it in the top 52.5%.
Is M1 Kliniken AG's EV-to-OCF too high?
M1 Kliniken AG's current EV-to-OCF of 9.52 is 41% below median its 10-year median of 16.26. The Medical Distribution industry median EV-to-OCF is 7.96. M1 Kliniken AG's value of 9.52 is 19.6% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #62 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 88/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's EV-to-OCF compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #62 out of 118 companies for EV-to-OCF. This places M1 Kliniken AG in the lower half of its industry. The industry median EV-to-OCF is 7.96. M1 Kliniken AG's value of 9.52 is 19.6% above this benchmark. While the company's 10-year median is 16.26 vs. the industry median of 7.96, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Distribution company?
The median EV-to-OCF among Medical Distribution companies is 7.96, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current EV-to-OCF of 9.52 is 19.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median EV-to-OCF is 7.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current EV-to-OCF is 9.52, which is 41% below median its own 10-year median of 16.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, M1 Kliniken AG (HAM:M12) is currently considered Modestly Overvalued. The stock's GF Value™ is €15.79, compared to a current price of €19.62 — trading 24.3% above its estimated fair value. The current EV-to-OCF is 9.52, which is 41% below median its 10-year median of 16.26 and 19.6% above the Medical Distribution industry median of 7.96. M1 Kliniken AG's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For M1 Kliniken AG (HAM:M12), the current EV-to-OCF is 9.52 as of Sep. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (HAM:M12) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of €19.62 is trading 24.3% above its estimated GF Value™ of €15.79.
GuruFocus considers M1 Kliniken AG to be Modestly Overvalued.
Key valuation signals for HAM:M12:
EV-to-OCF: 9.52 (41% below median its 10-year median of 16.26)
GF Value™: €15.79 vs. price of €19.62 (24.3% above fair value)
Industry Position: 19.6% above the Medical Distribution median (#62 of 118)
No single metric tells the full story. See the HAM:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
88GF Score
Get the complete analysis for HAM:M12
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:M12 has been successfully added to your 
